Statistics for Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023
Total visits
| views | |
|---|---|
| Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023 | 45 |
Total visits per month
| views | |
|---|---|
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 1 |
File Visits
| views | |
|---|---|
| Effectiveness of the adapted bivalent mRNA COVID-19 XBB.pdf | 25 |
Top country views
| views | |
|---|---|
| Portugal | 16 |
| United States | 10 |
| Australia | 4 |
| China | 4 |
| Japan | 2 |
| Angola | 1 |
| Canada | 1 |
| France | 1 |
| Ireland | 1 |
| Iran | 1 |
| Sweden | 1 |
Top city views
| views | |
|---|---|
| Braga | 3 |